Physician Issues | Addiction Professional Magazine Skip to content Skip to navigation

Physician Issues

Lakeview Health launches pain recovery program

October 11, 2017  |  Gary A. Enos, Editor
news
The Florida facility's new service for patients experiencing addiction and chronic pain will include a process group focused on pain recovery and peer support.

Hospitalized overdose patients sicker, costlier, more likely to die

August 29, 2017  |  Gary A. Enos, Editor
article
Research findings released this week point to growing critical care needs for opioid overdose victims, attributable in part to the transition to heroin.

Study examines opioid drug company payments to physicians

August 25, 2017  |  Gary A. Enos, Editor
news
A new study finds that one in five family physicians accepted some form of drug company payment related to opioid pharmaceuticals.

Missouri sets up PDMP at last, but with caveats

August 10, 2017  |  Julie Miller, Editor in Chief
article
Under Missouri's statewide prescription drug monitoring program, clinical professionals will not have access to patient-specific data to potentially prevent or treat addiction disorders.

Stigma apparent in physician replies to survey on buprenorphine prescribing

August 8, 2017  |  Gary A. Enos, Editor
article
A 2016 physician survey on the prescribing of buprenorphine does indicate that counselors and other specialty providers could help physicians overcome reluctance to prescribe the opioid dependence treatment.

Three keys to lowering mortality rates in opioid disorder patients

July 21, 2017  |  Alison Knopf, Contributing Writer
article
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.

Partnership in R.I. will accelerate buprenorphine training

July 13, 2017  |  Gary A. Enos, Editor
article
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.

Predictive testing company under fraud investigation

June 12, 2017  |  Gary A. Enos, Editor
news
Proove Biosciences, which markets technology designed to predict a patient's response to opioid dependence medications and other drugs, has had its office headquarters raided in an apparent healthcare fraud probe.

Rx Summit: Local solutions to crisis require collective effort

April 17, 2017  |  Gary A. Enos, Editor
article
Small counties in California are reducing improper opioid prescribing and expanding addiction treatment through the efforts of groups that include an insurer and a major foundation.

Role-playing technology assists health providers in substance use screening

April 16, 2017  |  Gary A. Enos, Editor
article
Use of health simulation technology is helping physicians, nurses and other general health providers take on what can be uncomfortable conversations with patients about substance use.

Ohio enacts limits on prescribing for acute pain

April 4, 2017  |  Gary A. Enos, Editor
news
New regulations on opioid prescribing in Ohio arrive at a time when some lawmakers are advocating even stricter limits.

Brightside Clinic hires medical director

March 20, 2017  |  Gary A. Enos, Editor
news
David Kushner, DO, FACP, has been named medical director at Brightside Clinic, the buprenorphine treatment organization with offices in two Illinois communities.

Pages

Subscribe to Physician Issues